NDC directory
Claudin 18.2-directed Cytolytic Antibodies list
Every FDA-approved prescription drug the FDA NDC directory tags with the Claudin 18.2-directed Cytolytic Antibody [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Map Vyloy and your other top fills to their generics
Rivvi lists each brand, its generics in RxNorm, and the brands with no generic.
Map my fillsThe FDA NDC directory lists 1 single-ingredient drug in this class: zolbetuximab.
Claudin 18.2-directed Cytolytic Antibodies (1)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Zolbetuximab | Vyloy | Single ingredient | 2 | Not controlled |
FDA established pharmacologic class: Claudin 18.2-directed Cytolytic Antibody [EPC].
Questions
What drugs are Claudin 18.2-directed Cytolytic Antibodies?
The FDA NDC directory lists 1 single-ingredient drug in this class: zolbetuximab.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.